Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Brian Temple

Pediatrics Austin, TX Medical Doctor

NPI 1689863649 CMS profile 167580

13917 W. Highway 71, Suite A, 13917 W. Highway 71, Suite A, Austin, TX 78738

Open in the dashboard

General payments

$5,762

342 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Brian Temple of Austin, TX is reported in the CMS Open Payments database as having received $5,762 across 342 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $697 38
2024 General $960 55
2023 General $784 44
2022 General $1,049 69
2021 General $1,241 73
2020 General $508 38
2019 General $522 25

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brian Temple
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Brian Temple were reported at $697. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Brian Temple Pediatrics median Middle half National median
2019 $522 $86 $31–$183 $163
2020 $508 $49 $22–$110 $114
2021 $1,241 $68 $27–$158 $132
2022 $1,049 $77 $30–$173 $149
2023 $784 $88 $33–$190 $160
2024 $960 $94 $34–$206 $164
2025 $697 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Ironshore Pharmaceuticals Inc. $1,532 82 payments
  2. Corium, Inc. $694 44 payments
  3. Neos Therapeutics, LP $658 62 payments
  4. Supernus Pharmaceuticals, Inc. $496 16 payments
  5. Tris Pharma Inc $428 28 payments
  6. Cranial Technologies, Inc $241 14 payments
  7. Collegium Pharmaceutical, Inc. $226 12 payments
  8. Vertical Pharmaceuticals, LLC $213 12 payments
  9. Takeda Pharmaceuticals U.S.A., Inc. $213 15 payments
  10. Adlon Therapeutics L.P. $187 10 payments
  11. Other $873 47 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $5,762 342 payments
Products named General payments · program years 2019–2025
  1. JORNAY PM Central Nervous Stimulant ADHD $799 39 payments
  2. Azstarys $694 44 payments
  3. JORNAY PM Central Nervous System Stimulant $605 41 payments
  4. COTEMPLA XR-ODT $491 43 payments
  5. Dyanavel XR $333 23 payments
  6. Adzenys XR-ODT Adhd $278 29 payments
  7. Doc Band $241 14 payments
  8. QELBREE Psychology $235 8 payments
  9. Adzenys XR-ODT Adhd $234 21 payments
  10. Qelbree Viloxazine Hydrochloride $229 6 payments
  11. Other $2,600 142 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

342 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatrics in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record